CTLA-4

Nithya Krishnamurthy1, Daisuke Nishizaki2, Scott M Lippman2

  • 1Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029-6574, USA.

概括

在瘤中高CTLA-4表达预测了接受免疫治疗的患者的更好的结果. 这种生物标志物,特别是与高PD-L1相结合时,表明免疫检查点抑制剂治疗的癌症患者的无进展和整体存活率有所改善.